Skip to main content
Equibles

Ameritas Investment Partners, Inc.

Position in GALT — Galectin Therapeutics Inc

CIK 1055980 LINCOLN, NE
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$20,179
+$17,746 QoQ
Shares Held
4,349
+118.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 98 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ameritas Investment Partners, Inc. holds $63,306,181 across 267 Biotechnology names. GALT ranks #207 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 12,422 $6,170,379
2 EXEL
Exelixis, Inc.
 75,969 $4,133,473
3 HALO
Halozyme Therapeutics, Inc.
 40,729 $3,187,858
4 CYTK
Cytokinetics Inc
 36,992 $3,151,348
5 ROIV
Roivant Sciences Ltd.
 83,064 $2,939,634
6 REGN
Regeneron Pharmaceuticals, Inc.
 4,593 $2,863,919
7 JAZZ
Jazz Pharmaceuticals plc
 11,547 $2,782,480
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 25,923 $2,112,983

All Filings in GALT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,179 4,349
2025-03-31 $2,433 1,995
2024-12-31 $2,573 1,995
2024-09-30 $5,486 1,995
2024-06-30 $4,508 1,995
2021-03-31 $6,173 2,845
2020-12-31 $6,372 2,845
2020-09-30 $7,596 2,845
2020-06-30 $8,705 2,845
2020-03-31 $5,576 2,845